MeSH term
Frequency | Condition_Probility | Animals | 54 | 0.0 |
Cell Death/drug effects | 2 | 1.0 |
Cell Line | 11 | 0.0 |
Cells, Cultured | 9 | 0.0 |
Growth Inhibitors/isolation & purification/*pharmacology | 2 | 50.0 |
Humans | 94 | 0.0 |
Neurons/*cytology/drug effects | 2 | 25.0 |
Rats | 20 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 40 | 0.0 |
Transfection | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 29 | 0.0 |
Amino Acid Sequence | 21 | 0.0 |
COS Cells | 3 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Base Sequence | 8 | 0.0 |
Cell Division | 3 | 0.0 |
Molecular Sequence Data | 23 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 7 | 0.0 |
Adult | 12 | 0.0 |
Female | 28 | 0.0 |
Male | 21 | 0.0 |
Middle Aged | 9 | 0.0 |
Rotation | 2 | 4.0 |
Aged | 7 | 0.0 |
Apoptosis/genetics | 2 | 0.0 |
Down-Regulation | 3 | 0.0 |
Glycosylation | 10 | 1.0 |
Mice | 22 | 0.0 |
Mice, Inbred BALB C | 4 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Mice, Transgenic | 3 | 0.0 |
*Prostatic Secretory Proteins | 21 | 23.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
Binding Sites | 6 | 0.0 |
Comparative Study | 9 | 0.0 |
Cysteine | 2 | 1.0 |
Kinetics | 7 | 0.0 |
Models, Molecular | 4 | 0.0 |
Nuclear Magnetic Resonance, Biomolecular | 3 | 1.0 |
Protein Conformation | 4 | 0.0 |
Protein Structure, Secondary | 3 | 0.0 |
Rabbits | 3 | 0.0 |
Thermodynamics | 2 | 0.0 |
Hybridomas | 5 | 3.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
T-Lymphocytes/*immunology | 4 | 0.0 |
T-Lymphocytes, Suppressor-Effector/immunology | 3 | 1.0 |
Aged, 80 and over | 3 | 0.0 |
Cross Reactions | 4 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 3 | 0.0 |
Immunoblotting | 5 | 0.0 |
Circular Dichroism | 5 | 1.0 |
Growth Inhibitors/*chemistry | 4 | 36.0 |
Nerve Tissue Proteins/*chemistry | 4 | 11.0 |
Neurons/*metabolism | 2 | 0.0 |
Apoptosis/physiology | 2 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Necrosis | 2 | 0.0 |
Nerve Tissue Proteins/*physiology | 2 | 3.0 |
Chronic Disease | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Alzheimer Disease/*metabolism | 6 | 2.0 |
Antibodies, Monoclonal | 4 | 0.0 |
Brain Injuries/*metabolism | 3 | 27.0 |
Rats, Sprague-Dawley | 5 | 0.0 |
Cadmium/chemistry | 3 | 42.0 |
Recombinant Proteins/biosynthesis/isolation & purification | 2 | 7.0 |
Spectrum Analysis | 2 | 3.0 |
Zinc/chemistry | 3 | 9.0 |
English Abstract | 12 | 0.0 |
Immunoglobulin G/biosynthesis | 2 | 1.0 |
Copper/chemistry | 2 | 10.0 |
Luminescent Measurements | 2 | 2.0 |
Magnetic Resonance Spectroscopy | 2 | 0.0 |
Metals, Heavy/*chemistry | 2 | 100.0 |
Brain Chemistry/*physiology | 3 | 5.0 |
Cattle | 3 | 0.0 |
Metallothionein/chemistry | 2 | 66.0 |
Growth Inhibitors/*physiology | 2 | 5.0 |
Nerve Tissue Proteins/*biosynthesis | 2 | 6.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Spectrophotometry | 2 | 1.0 |
Escherichia coli | 3 | 0.0 |
Lymphocyte Activation | 3 | 0.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Immunohistochemistry | 4 | 0.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Brain Chemistry | 2 | 0.0 |
Molecular Weight | 8 | 0.0 |
Sensitivity and Specificity | 3 | 0.0 |
Crystallography, X-Ray | 2 | 0.0 |
Macrophage Migration-Inhibitory Factors/*chemistry | 2 | 50.0 |
Recombinant Proteins/chemistry | 2 | 0.0 |
Chromatography, Affinity | 3 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 7 | 0.0 |
Gene Expression | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Animals, Newborn | 2 | 0.0 |
Cell Division/drug effects | 4 | 0.0 |
Chromatography, Gel | 4 | 0.0 |
Chromatography, High Pressure Liquid | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Dexamethasone/pharmacology | 3 | 0.0 |
Radioimmunoassay | 4 | 0.0 |
Electrophoresis, Gel, Two-Dimensional | 2 | 0.0 |
Lymphocytes/*metabolism | 2 | 1.0 |
Antibody Specificity | 3 | 0.0 |
Organ Specificity | 2 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Cloning, Molecular | 8 | 0.0 |
Growth Inhibitors/*genetics | 2 | 4.0 |
Sequence Homology, Nucleic Acid | 4 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Cell Survival/drug effects | 2 | 0.0 |
Brain/*metabolism | 2 | 0.0 |
Models, Biological | 2 | 0.0 |
Concanavalin A/pharmacology | 2 | 0.0 |
Feedback | 3 | 1.0 |
Lymphocyte Activation/drug effects | 3 | 0.0 |
Hybridomas/immunology | 2 | 1.0 |
T-Lymphocytes/immunology | 2 | 0.0 |
Fluorescent Antibody Technique | 3 | 0.0 |
Granulocytes/immunology | 2 | 3.0 |
Neutrophils/immunology | 2 | 1.0 |
Culture Media | 3 | 0.0 |
Heat | 2 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Corticosterone/blood | 2 | 5.0 |
Mice, Inbred Strains | 4 | 0.0 |
Blotting, Southern | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Exons | 2 | 0.0 |
Antigen-Antibody Complex/analysis | 2 | 1.0 |
Antilymphocyte Serum/analysis | 2 | 14.0 |
Granulocytes/*immunology | 3 | 8.0 |
Bee Venoms/*immunology | 2 | 28.0 |
In Vitro | 3 | 0.0 |
Annexins | 2 | 15.0 |
Calcium-Binding Proteins/pharmacology | 2 | 22.0 |
Immunoglobulin E/*biosynthesis | 4 | 8.0 |
T-Lymphocytes/*physiology | 2 | 0.0 |
Cytotoxicity, Immunologic | 2 | 0.0 |
Hybridomas/metabolism | 2 | 9.0 |
T-Lymphocytes/metabolism | 2 | 0.0 |
Antibody Formation | 2 | 0.0 |
Immune Tolerance | 2 | 0.0 |
HLA Antigens/analysis | 2 | 0.0 |
Pregnancy | 5 | 0.0 |
Immunodiffusion | 2 | 0.0 |
Somatostatin/*pharmacology | 3 | 6.0 |
